Skip to main content

Table 4 Patient characteristics and cardiac findings according to CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD Normal CMR Abnormal CMR p value
N = 63 N = 14 N = 49
Male, n (%) 63 (100) 14 (100) 49 (100) 1.00
Age, years 31 ± 15 25 ± 18 32 ± 14 0.11
BMD, n (%) 51 (81) 13 (93) 38 (78) 0.27
BMI, kg/m2 24 ± 4 23 ± 6 24 ± 4 0.75
Skeletal muscle status 0/1/2/3, n (%) 2 (3)/43 (68)/13 (21)/5 (8) 2 (14)/10 (71)/1 (7)/1 (7) 33 (67)/12 (25)/4 (8)/0 (0) 0.07
ACE inhibitor, n (%) 16 (25) 1 (7) 15 (31) 0.09
Beta-blocker, n (%) 14 (22) 1 (7) 13 (27) 0.16
CK, U/L 1226 (653-2424) 764 (596-2411) 1344 (783-2463) 0.24
Elevated hs-Trop, n (%)a 30 (48) 2 (14) 28 (57) 0.006
Elevated NT-proBNP, n (%)b 3 (5) 0 (0) 3 (6) 1.00
  1. a > 14 pg/mL; b > 450 pg/mL
  2. Bold text indicates a significant p-value of <0.05